Evidence map›Paper›PMID 32096368›Full record

ArticleJournal of biomedical optics2020

Surgical microscope with integrated fluorescence lifetime imaging for 5-aminolevulinic acid fluorescence-guided neurosurgery.

Mikael T Erkkilä, David Reichert, Nancy Hecker-Denschlag, Marco Wilzbach, Christoph Hauger, Rainer A Leitgeb, Johanna Gesperger, Barbara Kiesel, Thomas Roetzer, Georg Widhalm and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of biomedical optics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 3 countries.

Mikael T ErkkiläMedical University of Vienna, Center for Medical Physics and Biomedical Engineering, Vienna, Austria.
David ReichertMedical University of Vienna, Center for Medical Physics and Biomedical Engineering, Vienna, Austria.
Nancy Hecker-DenschlagCarl Zeiss Meditec AG, Advanced Development Microsurgery, Oberkochen, Germany.
Marco WilzbachCarl Zeiss Meditec AG, Advanced Development Microsurgery, Oberkochen, Germany.
Christoph HaugerCarl Zeiss Meditec AG, Advanced Development Microsurgery, Oberkochen, Germany.
Rainer A LeitgebMedical University of Vienna, Center for Medical Physics and Biomedical Engineering, Vienna, Austria.
Johanna GespergerMedical University of Vienna, Center for Medical Physics and Biomedical Engineering, Vienna, Austria.
Barbara KieselGeneral Hospital and Medical University of Vienna, Department of Neurosurgery, Vienna, Austria.
Thomas RoetzerGeneral Hospital and Medical University of Vienna, Institute of Neurology, Vienna, Austria.
Georg WidhalmGeneral Hospital and Medical University of Vienna, Department of Neurosurgery, Vienna, Austria.
Wolfgang DrexlerMedical University of Vienna, Center for Medical Physics and Biomedical Engineering, Vienna, Austria.
Angelika UnterhuberMedical University of Vienna, Center for Medical Physics and Biomedical Engineering, Vienna, Austria.
Marco AndreanaMedical University of Vienna, Center for Medical Physics and Biomedical Engineering, Vienna, Austria.
Vienna General Hospital · ATCarl Zeiss (Germany) · DECarl Zeiss (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

significance5-Aminolevulinic acid (5-ALA)-based fluorescence guidance in conventional neurosurgical microscopes is limited to strongly fluorescent tumor tissue. Therefore, more sensitive, intrasurgical 5-ALA fluorescence visualization is needed.

aimMacroscopic fluorescence lifetime imaging (FLIM) was performed ex vivo on 5-ALA-labeled human glioma tissue through a surgical microscope to evaluate its feasibility and to compare it to fluorescence intensity imaging. APPROACH: Frequency-domain FLIM was integrated into a surgical microscope, which enabled parallel wide-field white-light and fluorescence imaging. We first characterized our system and performed imaging of two samples of suspected low-grade glioma, which were compared to histopathology.

resultsOur imaging system enabled macroscopic FLIM of a 6.5  ×  6.5  mm2 field of view at spatial resolutions <20  μm. A frame of 512  ×  512  pixels with a lifetime accuracy <1  ns was obtained in 65 s. Compared to conventional fluorescence imaging, FLIM considerably highlighted areas with weak 5-ALA fluorescence, which was in good agreement with histopathology.

conclusionsIntegration of macroscopic FLIM into a surgical microscope is feasible and a promising method for improved tumor delineation.

Indexed as

Brain NeoplasmsNeurosurgeryAminolevulinic AcidFluorescenceHumansOptical ImagingPhotosensitizing AgentsProtoporphyrinsAminolevulinic AcidPhotosensitizing AgentsProtoporphyrinsfluorescence-guided neurosurgeryfluorescence lifetime imagingprotoporphyrin IXsurgical microscope

Identifiers

PMID32096368
PMCPMC7039165
OpenAlexW3007808027

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.